Genetic Modification of Smooth Muscle Cells to Control Phenotype and Function in Vascular Tissue Engineering

Tissue Engineering

Volumn 10, Issue 1-2, 2004, Pages 189-199

  Stegemann, Jan P ^a,b   Dey, Nupur B ^c,d   Lincoln, Thomas M ^c,d   Nerem, Robert M ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; COLLAGEN TYPE 1; CONTRACTILE PROTEIN; CYCLIC GMP DEPENDENT PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR BB; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DNA MODIFICATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; MECHANICAL STIMULATION; MONOLAYER CULTURE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STIMULATION; TISSUE ENGINEERING; VASCULAR TISSUE;

ANIMALS; AORTA; BIOCOMPATIBLE MATERIALS; COLLAGEN; MYOCYTES, SMOOTH MUSCLE; PHENOTYPE; RATS; TIME FACTORS; TISSUE ENGINEERING; TRANSFECTION;

EID: 1042301231     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/107632704322791844     Document Type: Article

References (30)

1. Thyberg, J., and Hultgard-Nilsson, A. Fibronectin and the basement membrane components laminin and collagen type IV influence the phenotypic properties of subcultured rat aortic smooth muscle cells differently. Cell Tissue Res. 276, 263, 1994.
2. Hedin, U., Thyberg, J., Roy, J., Dumitrescu, A., and Tran, P.K. Role of tyrosine kinases in extracellular matrix-mediated modulation of arterial smooth muscle cell phenotype, Arterioscler. Thromb. Vasc. Biol. 17, 1977, 1997.
3. 1 promotes the morphological and functional differentiation of the myofibroblast. Exp. Cell Res. 257, 180, 2000.
4. Lewis, C.D., Olson, N.E., Raines, E.W., Reidy, M.A., and Jackson, C.L. Modulation of smooth muscle proliferation in rat carotid artery by platelet-derived mediators and fibroblast growth factor-2. Platelets 12, 352, 2001.
5. Niklason, L.E., Gao, J., Abbott, W.M., Hirschi, K.K., Houser, S., Marini, R., and Langer, R. Functional arteries grown in vitro. Science 284, 489, 1999.
6. Chapman, G.B., Durante, W., Hellums, J.D., and Schafer, A.I. Physiological cyclic stretch causes cell cycle arrest in cultured vascular smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 278, H748, 2000.
7. Stegemann, J.P., and Nerem, R.M. Phenotype modulation in vascular tissue engineering using biochemical and mechanical stimulation. Ann. Biomed. Eng. 31, 391, 2003.
8. Cukierman, E., Pankov, R., Stevens, D.R., and Yamada, K.M. Taking cell-matrix adhesions to the third dimension. Science 294, 1708, 2001.
9. Stegemann, J.P., and Nerem, R.M. Altered response of vascular smooth muscle cells to exogenous biochemical stimulation in two- and three-dimensional culture. Exp. Cell Res. 283, 146, 2003.
10. Nerem, R.M., and Sambanis, A. Tissue engineering: From biology to biological substitutes. Tissue Eng. 1, 3, 1995.
11. Salyapongse, A.N., Billiar, T.R., and Edington, H. Gene therapy and tissue engineering. Clin. Plast. Surg. 26, 663, 1999.
12. Mulligan, R.C. The basic science of gene therapy. Science 260, 926, 1993.
13. Hamm, A., Krott, N., Breibach, I., Blindt, R., and Boserhoff, A.K. Efficient transfection method for primary cells. Tissue Eng. 8, 235, 2002.
14. Firulli, A.B., Han, D., Kelly-Roloff, L., Koteliansky, V.E., Schwartz, S.M., Olson, E.N., and Miano, J.M. A comparative molecular analysis of four rat smooth muscle cell lines. In Vitro Cell. Dev. Biol. Anim. 34, 217, 1998.
15. Geary, R.L., Clowes, A.W., Lau, S., Vergel, S., Dale, D.C., and Osborne, W.R.A. Gene transfer in baboons using prosthetic vascular grafts seeded with retrovirally transduced smooth muscle cells: A model for local and systemic gene therapy. Hum. Gene Ther. 5, 1211, 1994.
16. Flugelman, M.Y. Inhibition of intravascular thrombosis and vascular smooth muscle cell proliferation by gene therapy. Thromb. Haemost. 74, 406, 1995.
17. Gibbons, G.H., and Dzau, V.J. Molecular therapies for vascular diseases. Science 272, 689, 1996.
18. Mann, M.J., and Dzau, V.J. Genetic manipulation of vein grafts. Curr. Opin. Cardiol. 12, 522, 1997.
19. Doi, K., Itoh, H., Ikeda, T., Hosada, K., Ogawa, Y., Igaki, T., Yamashita, J., Chun, T.H., Inoue, M., Masatsugu, K., Matsuda, K., Ohmori, K., and Nakao, K. Adenovirus-mediated gene transfer of C-type natriuretic peptide causes G1 growth inhibition of cultured vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 239, 889, 1997.
20. Jiang, Z., Grange, R.W., Walsh, M.P., and Kamm, K.E. Adenovirus-mediated transfer of the smooth muscle cell calponin gene inhibits proliferation of smooth muscle cells and fibroblasts. FEBS Lett. 413, 441, 1997.
21. Denger, S., Jahn, L., Wende, P., Watson, L., Gerber, S.H., Kuebler, W., and Kreuzer, J. Expression of monocyte chemoattractant protein-1 cDNA in vascular smooth muscle cells: Induction of the synthetic phenotype, a possible clue to SMC differentiation in the process of atherogenesis. Atherosclerosis 144, 15, 1999.
22. Boerth, N.J., Dey, N.B., Cornwell, T.L., and Lincoln, T.M. Cyclic GMP-dependent protein kinase regulates vascular smooth muscle cell phenotype. J. Vasc. Res. 34, 245, 1997.
23. Dey, N.B., Boerth, N.J., Murphy-Ullrich, J.E., Chang, P.L., Prince, C.W., and Lincoln, T.M. Cyclic GMP-dependent protein kinase inhibits osteopontin and thrombospondin production in rat aortic smooth muscle cells. Circ. Res. 82, 139, 1998.
24. Lincoln, T.M., Dey, N.B., Boerth, N.J., Cornwell, T.L., and Soff, G.A. Nitric oxide-cyclic GMP pathway regulates vascular smooth muscle cell phenotypic modulation: Implications in vascular diseases. Acta Physiol. Scand. 164, 507, 1998.
25. Brophy, C.M., Woodrum, D.A., Pollock, J., Dickinson, M., Komalavilas, P., Cornwell, T.L., and Lincoln, T.M. cGMP-dependent protein kinase expression restores contractile function in cultured vascular smooth muscle cells. J. Vasc. Res. 140, 1, 2002.
26. Chiche, J.D., Schlutsmeyer, S.M., Bloch, D.B., delaMonte, S. M., Roberts, J.D., Filippov, G., Janssens, S.P., Rosenzweig, A., and Bloch, K.D. Andenovirus-mediated gene transfer of cGMP-dependent protein kinase increases the sensitivity of cultured vascular smooth muscle cells to the antiproliferative and pro-apoptotic effects of nitric oxide/cGMP. J. Biol. Chem. 273, 34263, 1998.
27. Seliktar, D., Black, R.A., Vito, R.P., and Nerem, R.M. Dynamic mechanical conditioning of collagen-gel blood vessel constructs induces remodeling in vitro. Ann. Biomed. Eng. 28, 351, 2000.
28. Nilsen-Hamilton, M. Transforming growth factor-β and its action on cellular growth and differentiation. Curr. Top. Dev. Biol. 24, 95, 1990.
29. Stringa, E., Knauper, V., Murphy, G., and Gavrilovic, J. Collagen degradation and platelet-derived growth factor stimulate the migration of vascular smooth muscle cells. J. Cell Sci. 113, 2055, 2000.
30. Mann, B.K., Schmedlen, R.H., and West, J.L. Tethered-TGF-β increases extracellular matrix production of vascular smooth muscle cells. Biomaterials 22, 439, 2001.